2B70.DE vs. WH2E.DE
2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) and WH2E.DE (Invesco S&P World Health Care ESG UCITS ETF Acc) are both Health & Biotech Equities funds - 2B70.DE tracks the Nasdaq Biotechnology while WH2E.DE tracks the S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care. Both are passively managed. Over the past 3 years, 2B70.DE returned 14.71%/yr vs 5.05%/yr for WH2E.DE. A 0.60 correlation means they provide meaningful diversification when combined. 2B70.DE charges 0.35%/yr vs 0.18%/yr for WH2E.DE.
Performance
2B70.DE vs. WH2E.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B70.DE achieves a 14.41% return, which is significantly higher than WH2E.DE's -0.57% return.
2B70.DE
- 1D
- 0.86%
- 1M
- 10.24%
- YTD
- 14.41%
- 6M
- 14.41%
- 1Y
- 54.92%
- 3Y*
- 14.71%
- 5Y*
- 6.01%
- 10Y*
- —
WH2E.DE
- 1D
- 0.00%
- 1M
- 3.97%
- YTD
- -0.57%
- 6M
- -0.23%
- 1Y
- 15.63%
- 3Y*
- 5.05%
- 5Y*
- —
- 10Y*
- —
2B70.DE vs. WH2E.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 14.41% | 18.57% | 4.69% | 4.35% |
WH2E.DE Invesco S&P World Health Care ESG UCITS ETF Acc | -0.57% | 2.78% | 7.94% | 1.65% |
Correlation
The correlation between 2B70.DE and WH2E.DE is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.65 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Apr 17, 2023 | 0.60 |
The correlation between 2B70.DE and WH2E.DE has been stable across timeframes, ranging from 0.60 to 0.65 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B70.DE vs. WH2E.DE — Risk / Return Rank
2B70.DE
WH2E.DE
2B70.DE vs. WH2E.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| 2B70.DE | WH2E.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.74 | ||
| Sortino ratioReturn per unit of downside risk | +2.07 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.19 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 8.71 | 1.28 | +7.43 |
| Martin ratioReturn relative to average drawdown | 25.37 | 3.25 | +22.12 |
Loading charts...
Drawdowns
2B70.DE vs. WH2E.DE - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.92%, which is greater than WH2E.DE's maximum drawdown of -22.19%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and WH2E.DE.
Loading charts...
Drawdown Indicators
| 2B70.DE | WH2E.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.92% | -22.19% | -8.73% |
Max Drawdown (1Y)Largest decline over 1 year | -6.28% | -12.23% | +5.95% |
Max Drawdown (3Y)Largest decline over 3 years | -29.42% | -22.19% | -7.23% |
Max Drawdown (5Y)Largest decline over 5 years | -30.92% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -7.98% | +7.98% |
Average DrawdownAverage peak-to-trough decline | -11.75% | -6.98% | -4.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.16% | 4.82% | -2.66% |
Volatility
2B70.DE vs. WH2E.DE - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 6.66% compared to Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE) at 5.13%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than WH2E.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B70.DE | WH2E.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.66% | 5.13% | +1.53% |
Volatility (6M)Calculated over the trailing 6-month period | 15.00% | 10.80% | +4.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.69% | 15.17% | +4.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.49% | 13.93% | +6.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.35% | 13.93% | +8.42% |
2B70.DE vs. WH2E.DE - Expense Ratio Comparison
2B70.DE has a 0.35% expense ratio, which is higher than WH2E.DE's 0.18% expense ratio.
Dividends
2B70.DE vs. WH2E.DE - Dividend Comparison
Neither 2B70.DE nor WH2E.DE has paid dividends to shareholders.
Frequently Asked Questions
2B70.DE and WH2E.DE have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WH2E.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WH2E.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for 2B70.DE.
2B70.DE tracks Nasdaq Biotechnology, while WH2E.DE tracks S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care. They also come from different issuers: iShares and Invesco. Their fees differ too: 0.35% for 2B70.DE and 0.18% for WH2E.DE.
Find the right allocation for 2B70.DE and WH2E.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer